Ruiyang Xie

National Cancer Center, Chinese Academy of Medical Sciences

Ruiyang Xie, M.D
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Urologist, expertise in minimally invasivesurgery of kidney cancer, prostate cancer, and bladder cancer. MDT member in National Cancer Center Urology. Accumulated experience in genomic analysis and molecular biology.

Disclosure information not submitted.

Presentation(s):

• MP12-16: Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: a systematic review and network meta-analysis of safety

  Friday, May 13, 2022
  1:00 PM – 2:15 PM